Chronic daily headache with medication overuse: predictors of outcome 1 year after withdrawal therapy

Eur J Neurol. 2009 Jun;16(6):705-12. doi: 10.1111/j.1468-1331.2009.02571.x. Epub 2009 Feb 19.

Abstract

Background and purpose: We examined prospectively the results of withdrawal therapy in 80 patients with probable medication overuse headache. The aim was to identify baseline patient characteristics that might predict outcome after 1 year (end of study).

Methods: We classified patients according to results of withdrawal therapy measured as the improvement of headache days (HD) from baseline to end of study.

Results: Thirty-six per cent (29/80) had at least 50% improvement. Sixty-four per cent (51/80) had <50% improvement, and among these, 30% (24/80) had <10% improvement. The following baseline characteristics were associated with poor outcome of withdrawal therapy: use of codeine-containing drugs, low self-reported sleep quality, and high self-reported bodily pain as measured by the quality of life tool SF-36.

Conclusion: Before suggesting withdrawal therapy, one should probably pay more close attention to sleep problems.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Analgesics / adverse effects*
  • Analgesics, Opioid / adverse effects
  • Causality
  • Codeine / adverse effects
  • Female
  • Follow-Up Studies
  • Headache Disorders / chemically induced*
  • Headache Disorders / therapy*
  • Headache Disorders, Secondary / therapy*
  • Humans
  • Male
  • Middle Aged
  • Norway
  • Pain Measurement
  • Patient Selection
  • Predictive Value of Tests
  • Prognosis
  • Prospective Studies
  • Self-Assessment
  • Sleep Wake Disorders / complications
  • Substance Withdrawal Syndrome*
  • Time
  • Treatment Outcome

Substances

  • Analgesics
  • Analgesics, Opioid
  • Codeine